Notice of Results
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) announced its intention to release its half-yearly results for the six months ended June 30, 2025, on Thursday, August 28, 2025. A presentation and conference call for analysts and shareholders is scheduled for 9:00 am EDT / 2:00 pm BST on the same day, with a webcast available on the company's website. The company is a clinical-stage biotherapeutics company with a portfolio of 29 therapeutics and therapeutic candidates, including three approved by the U.S. Food and Drug Administration.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to announce its half-yearly results for the six months ended June 30, 2025, on Thursday, August 28, 2025.
A presentation and conference call for analysts and shareholders will take place at 9:00am EDT / 2:00pm BST on the day of publication, and a webcast of the presentation will be available on the Company's website at https://investors.puretechhealth.com/events-presentations.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.